Fluidigm Corporation Accelerates Single-Cell Science With The New C1™ Open App™ Program

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today announced the launch of the C1TM Open AppTM Program, giving researchers the ability to create and share new single-cell applications on the C1 Single-Cell Auto Prep System.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC